dockets: FDA-2026-P-8286
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | title | docket_type | last_modified | object_id | rin | dkabstract | category | subtype | keywords | program | short_title | effective_date | organization | attrs_raw | attr_source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-P-8286 | FDA | Request that the FDA determine whether DDAVP (desmopressin acetate) Nasal Spray, 0.01 mg/Spray (Needs No Refrigeration), Product No. 003 approved under New Drug Application (NDA) number 017922, held by Ferring Pharmaceuticals, Inc., has been voluntarily withdrawn for reasons of safety or effectiveness. | Nonrulemaking | 2026-09-15T20:37:09Z | 0b000064b93d1750 | list_pull |
Links from other tables
- 3 rows from docket_id in documents